Healthcare Distribution Specialists (HDS), a wholly owned subsidiary of Sunpeaks Ventures, has signed a letter of intent with PharmaLife to export Clotamin to pharmacies in the Russian Federation.
Subscribe to our email newsletter
The proposed transaction could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation.
PharmaLife is also expected to make safe, timely product registration within the Russian Federation for Clotamin distribution.
Sunpeaks CEO Mackie Barch said: "We look forward to working closely with PharmaLife and our new possible distributors to build market awareness and sales of Clotamin across Russia."
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.